DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance.

Autor: Conway K; Department of Epidemiology, University of North Carolina, Chapel Hill, NC.; Department of Dermatology, University of North Carolina, Chapel Hill, NC.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC., Edmiston SN; Department of Dermatology, University of North Carolina, Chapel Hill, NC.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC., Vondras A; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC., Reiner A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Corcoran DL; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC., Shen R; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Parrish EA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC., Hao H; Department of Dermatology, University of North Carolina, Chapel Hill, NC., Lin L; Department of Dermatology, University of North Carolina, Chapel Hill, NC., Kenney JM; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Ilelaboye G; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Kostrzewa CE; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Kuan PF; Department of Applied Mathematics and Statistics, State University of New York, Stony Brook, NY., Busam KJ; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Lezcano C; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Lee TK; British Columbia Cancer Research Center, Vancouver, BC, Canada., Hernando E; Grossman School of Medicine, New York University, New York, NY., Googe PB; Department of Dermatology, University of North Carolina, Chapel Hill, NC.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC., Ollila DW; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC., Moschos S; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC., Gorlov I; Department of Medicine, Baylor Medical Center, Houston, TX., Amos CI; Department of Medicine, Baylor Medical Center, Houston, TX., Ernstoff MS; ImmunoOncology Branch, National Cancer Institute, Rockville, MD., Cust AE; The Daffodil Centre, The University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, NSW, Australia.; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia.; Sydney School of Public Health, The University of Sydney, Sydney, NSW, Australia., Wilmott JS; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia., Scolyer RA; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia., Mann GJ; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia.; John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Vergara IA; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia., Ko J; Cleveland Clinic Foundation, Cleveland, OH., Rees JR; Department of Epidemiology, Dartmouth Medical School, Lebanon, NH., Yan S; Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH., Nagore E; Instituto Valenciano de Oncologia, Valencia, Spain.; Universidad Católica de Valencia San Vicente Mártir, Valencia, Spain., Bosenberg M; Department of Pathology, Yale University, New Haven, CT., Rothberg BG; Leonard Miller School of Medicine, University of Miami, Miami, FL., Osman I; Grossman School of Medicine, New York University, New York, NY., Lee JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Saenger Y; Columbia University Medical School, New York, NY.; Albert Einstein School of Medicine, New York, NY., Bogner P; Departments of Pathology and Dermatology, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Thompson CL; Case Western Reserve University, Cleveland, OH.; Penn State University, Hershey, PA., Gerstenblith M; Case Western Reserve University, Cleveland, OH., Holmen SL; Department of Surgery, University of Utah Health Sciences Center and Huntsman Cancer Institute, Salt Lake City, UT., Funchain P; Stanford University, Palo Alto, CA., Brunsgaard E; Department of Dermatology, Rush University Medical Center, Chicago, IL., Depcik-Smith ND; GPA Laboratories, Sonic Healthcare, Greensboro, NC., Luo L; Department of Internal Medicine and the UNM Comprehensive Cancer Center, Albuquerque, NM., Boyce T; Department of Internal Medicine and the UNM Comprehensive Cancer Center, Albuquerque, NM., Orlow I; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Begg CB; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Berwick M; Department of Internal Medicine and the UNM Comprehensive Cancer Center, Albuquerque, NM., Thomas NE; Department of Dermatology, University of North Carolina, Chapel Hill, NC.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.

Publikováno v: JCO precision oncology [JCO Precis Oncol] 2024 Nov; Vol. 8, pp. e2400375. Date of Electronic Publication: 2024 Nov 07.